Skip to main content

Walleye Capital LLC

Position in KURA — Kura Oncology, Inc.

CIK 1758720 NEW YORK, NY

Position in KURA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,798,396
+$1,759,517 QoQ
Shares Held
221,205
+5811.4% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in KURA Over Time

Shares Held

Position Value (USD)

Derivatives in KURA

reported options exposure · as of Mar 31, 2026
CallValue
$243,900
CallShares
30,000
PutValue
$55,284
PutShares
6,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. KURA ranks #40 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KURA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $243,900 30,000
2026-03-31 $1,798,396 221,205
2026-03-31 $55,284 6,800
2025-12-31 $119,485 11,500
2025-12-31 $38,879 3,742
2025-12-31 $110,134 10,600
2025-06-30 $2,390,637 414,322
2025-03-31 $3,332,056 504,857
2024-12-31 $4,671,329 536,318
2024-09-30 $166,090 8,500
2024-09-30 $212,986 10,900
2024-09-30 $11,164,472 571,365
2024-06-30 $232,667 11,300
2024-06-30 $249,139 12,100
2024-06-30 $1,545,917 75,081
2024-03-31 $1,775,765 83,252
2024-03-31 $23,463 1,100
2023-12-31 $654,893 45,542
2023-09-30 $2,415,824 264,893
2023-06-30 $874,669 82,672
2022-09-30 $3,661,890 268,074
2021-06-30 $437,641 20,990